Cowen Starts Versartis (VSAR) at Outperform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/12/2026
- US stocks close down as oil spikes 12%, job market weakens
- U.S. nonfarm payroll employment unexpectedly falls in February
- Oracle stock falls on report of scrapped Texas data center plans
- Kuwait cuts oil output as storage fills up
- Boeing reportedly nearing 500-aircraft deal with China ahead of Trump visit
- After-hours movers: Marvell, Samsara, GAP, Cooper Cos.
- After-hours movers: Broadcom, StubHub, Cracker Barrel, Grocery Outlet, Veeva Systems and more
- After-hours movers: Moderna, CrowdStrike, Ross Stores, Box and more
- After-hours movers: MongoDB, Credo, SoFi Technologies and more
- After-hours movers: Dell, Block, CoreWeave, Autodesk, MARA and more
Citi Starts Versartis (VSAR) at Buy
April 15, 2014 7:05 AM UTCCiti initiated coverage on Versartis (NASDAQ: VSAR) with a Buy rating and a price target of $60.00.
For an analyst ratings summary and ratings history on Versartis click here. For more ratings news on Versartis click here.
Shares of Versartis closed at $24.56 yesterday.
... MoreMorgan Stanley Starts Versartis (VSAR) at Overweight
April 15, 2014 7:04 AM UTCMorgan Stanley initiated coverage on Versartis (NASDAQ: VSAR) with an Overweight rating and a price target of $79.00.
For an analyst ratings summary and ratings history on Versartis click here. For more ratings news on Versartis click here.
Shares of Versartis closed at $24.56 yesterday.
... MoreUPDATE: Canaccord Genuity Starts Versartis (VSAR) at Buy
April 15, 2014 7:03 AM UTC(Updated - April 15, 2014 11:38 AM EDT)
Canaccord Genuity initiated coverage on Versartis (NASDAQ: VSAR) with a Buy rating and a price target of $36.00.
"We believe Versartis product treating growth hormone deficiency is differentiated molecularly and provides significant advantages over current treatment including... More
